STN: BL 125546
Proper Name: Meningococcal Group B Vaccine
Trade Name: BEXSERO
Manufacture: Novartis Vaccines and Diagnostics, Inc
- Active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age.
FDA approves a second vaccine to prevent serogroup B meningococcal disease
Press Release, January 23, 2015